Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06536244
Status:
WITHDRAWN
Last Update Posted:
None
First Post:
2024-07-23
Brief Title:
Impact of Perioperative Anesthetic Management on Renal Cancer Progression
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Impact of Perioperative Anesthetic Management on Renal Cancer Progression
Status:
WITHDRAWN
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Withdrawn
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The relationship between perioperative drugs including preoperative medications anesthetics and analgesics and postoperative outcomes in cancer patients is a complex and evolving field of study Understanding how those medications might impact outcomes such as pain acute kidney injury and recurrence is crucial for optimizing perioperative care in renal cancer patients
Detailed Description:
This retrospective study will investigate the association of perioperative drugs on short and long-term postoperative outcomes in patients undergoing kidney surgeries for renal cell carcinoma
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None